Institutional and Insider Selling Hits Bristol Myers Squibb and Bank of America

Bristol Myers Squibb (BMY) and Bank of America (BAC) are witnessing significant institutional and insider selling, signaling a cautious shift in market sentiment. At BMY, Trust Co. of Toledo NA OH slashed its position by 35%, while Executive VP David Elkins sold shares worth $1.85 million following a recent earnings miss. Similarly, Myriad Asset Management US LP reduced its stake in Bank of America by 72% during the fourth quarter, offloading 26,724 shares. BAC insiders have also divested shares totaling over $11 million, although institutional investors still maintain a substantial 70.71% ownership stake. Despite these sell-offs, analyst sentiment remains divided; BMY holds a consensus 'Hold' rating, whereas BAC maintains a 'Moderate Buy' with an average price target of $59.54. These combined movements highlight varying levels of confidence across the healthcare and financial sectors amid evolving market conditions.